First line treatment of adult patients with primary immune thrombocytopenia: a real-world study-Reference-Cited by-同舟云学术

First line treatment of adult patients with primary immune thrombocytopenia: a real-world study

Published:2019-02-11 Issue:1 Volume:31 Page:55-61
ISSN:0953-7104
Container-title:Platelets
language:en
Short-container-title:Platelets

Author:

Wang Liang¹²³,Xu Lei²,Hao Hongyuan⁴,Jansen A. J. Gerard⁵^ORCID,Liu Guoqiang²,Li Honglei²,Liu Xinguang¹,Zhao Yajing¹,Peng Jun¹³⁶,Hou Ming¹³⁷

Affiliation:

1. Department of Hematology, Qilu Hospital, Shandong University, Jinan, China

2. Department of Hematology, Shengli Oilfield Central Hospital, Dongying, China

3. Shandong Provincial Key Laboratory of Immunohematology, Qilu Hospital, Shandong University, Jinan, China

4. Department of Hematology, Qilu Hospital of Shandong University (Qingdao), Qingdao, China

5. Department of Hematology, Erasmus University Medical Center, Rotterdam, The Netherlands

6. Key Laboratory of Cardiovascular Remodeling and Function Research, Chinese Ministry of Education and Chinese Ministry of Health, Qilu Hospital, Shandong University, Jinan, China

7. Leading Research Group of Scientific Innovation, Department of Science and Technology of Shandong Province, Qilu Hospital, Shandong University, Jinan, China

Funder

National Natural Science Foundation of China

Shandong Provincial Key Laboratory of Immunohematology Open Research Program

Major Research Plan of Natural Science Foundation of Shandong Province

Publisher

Informa UK Limited

Subject

Hematology,General Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1080/09537104.2019.1572875

Reference27 articles.

1. Standardization of terminology, definitions and outcome criteria in immune thrombocytopenic purpura of adults and children: report from an international working group